Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Nature Reviews. Clinical Oncology|April 5, 2012
Molecular prescreening to select patient population in early clinical trialsJordi Rodón, Cristina Saura, Rodrigo Dienstmann, et al.
Expert Opinion on Biological Therapy|August 1, 2022
Biologics in rectal cancerAlexandre A Jácome, Renata D'Alpino Peixoto, Mariana V Gil, et al.
Cancer Treatment Reviews|February 10, 2022
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysisGuillermo Villacampa, Pablo Tolosa, Fernando Salvador, et al.
Molecular Oncology|April 29, 2014
Standardized decision support in next generation sequencing reports of somatic cancer variantsRodrigo Dienstmann, Fei Dong, Darrell Borger, et al.
JCO Global Oncology|October 19, 2023
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian PerspectiveBruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa E Silva, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 15, 2015
Intrinsic cancer subtypes--next steps into personalized medicineCristina Santos, Rebeca Sanz-Pamplona, Ernest Nadal, et al.
JCO Precision Oncology|February 1, 2022
<i>RNF43</i>- and <i>NOTCH1</i>-Mutated Chemotherapy and Anti-EGFR-Refractory Colorectal Cancer: Should Clonality Guide Target Prioritization With Investigational Therapies?Susana Aguilar, Cristina Santos, Giulia Martini, et al.
Current Treatment Options in Oncology|November 6, 2021
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal CancerJavier Ros, Iosune Baraibar, Giulia Martini, et al.
Scientific Reports|July 27, 2025
Validation of a rapid biomarker assay for lung cancer using the IntelliPlex panelSandra Satie Koide, Breno Jeha Araújo, Juliana Doblas Massaro, et al.
JCO Precision Oncology|August 8, 2022
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology RegistryChristophe Le Tourneau, Camille Perret, Allan Hackshaw, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Nature Reviews. Clinical Oncology|April 5, 2012
Molecular prescreening to select patient population in early clinical trialsJordi Rodón, Cristina Saura, Rodrigo Dienstmann, et al.
Expert Opinion on Biological Therapy|August 1, 2022
Biologics in rectal cancerAlexandre A Jácome, Renata D'Alpino Peixoto, Mariana V Gil, et al.
Cancer Treatment Reviews|February 10, 2022
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysisGuillermo Villacampa, Pablo Tolosa, Fernando Salvador, et al.
Molecular Oncology|April 29, 2014
Standardized decision support in next generation sequencing reports of somatic cancer variantsRodrigo Dienstmann, Fei Dong, Darrell Borger, et al.
JCO Global Oncology|October 19, 2023
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian PerspectiveBruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa E Silva, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 15, 2015
Intrinsic cancer subtypes--next steps into personalized medicineCristina Santos, Rebeca Sanz-Pamplona, Ernest Nadal, et al.
JCO Precision Oncology|February 1, 2022
<i>RNF43</i>- and <i>NOTCH1</i>-Mutated Chemotherapy and Anti-EGFR-Refractory Colorectal Cancer: Should Clonality Guide Target Prioritization With Investigational Therapies?Susana Aguilar, Cristina Santos, Giulia Martini, et al.
Current Treatment Options in Oncology|November 6, 2021
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal CancerJavier Ros, Iosune Baraibar, Giulia Martini, et al.
Scientific Reports|July 27, 2025
Validation of a rapid biomarker assay for lung cancer using the IntelliPlex panelSandra Satie Koide, Breno Jeha Araújo, Juliana Doblas Massaro, et al.
JCO Precision Oncology|August 8, 2022
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology RegistryChristophe Le Tourneau, Camille Perret, Allan Hackshaw, et al.
Pageof 18